HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hayato Yamazaki Selected Research

Adalimumab (Humira)

9/2016Risk for malignancy in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs compared to the general population: A nationwide cohort study in Japan.
7/2014A comparison of incidence and risk factors for serious adverse events in rheumatoid arthritis patients with etanercept or adalimumab in Korea and Japan.
10/2010A case of adalimumab-associated interstitial pneumonia with rheumatoid arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hayato Yamazaki Research Topics

Disease

9Rheumatoid Arthritis
12/2020 - 10/2010
4Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
01/2020 - 04/2011
3Rheumatic Diseases (Rheumatism)
01/2020 - 07/2013
2Interstitial Lung Diseases (Interstitial Lung Disease)
02/2011 - 10/2010
1Peripheral Arterial Disease
10/2023
1Autoimmune Diseases (Autoimmune Disease)
11/2019
1Chronic Disease (Chronic Diseases)
11/2019
1Fatigue
11/2019
1Neuromyelitis Optica (Devic's Disease)
11/2019
1Pain (Aches)
11/2019
1Arthritis (Polyarthritis)
06/2018
1Neoplasms (Cancer)
09/2016
1Vasculitis (Vasculitides)
01/2016
1Aneurysm (Aneurysms)
01/2016
1Infections
12/2014
1Pneumonia (Pneumonitis)
07/2013
1Takayasu Arteritis (Arteritis, Takayasu's)
07/2012
1Respiratory Insufficiency (Respiratory Failure)
02/2011
1Purpura
01/2011
1Cough
10/2010
1Disease Progression
10/2010

Drug/Important Bio-Agent (IBA)

3Abatacept (Orencia)FDA Link
12/2020 - 09/2016
3Adalimumab (Humira)FDA Link
09/2016 - 10/2010
3tocilizumab (atlizumab)FDA Link
09/2016 - 11/2012
3Etanercept (Enbrel)FDA Link
09/2016 - 11/2012
2Antirheumatic Agents (DMARD)IBA
12/2020 - 09/2016
2Trimethoprim (Proloprim)FDA LinkGeneric
01/2020 - 01/2017
2Prednisolone (Predate)FDA LinkGeneric
01/2020 - 01/2017
2SulfamethoxazoleFDA LinkGeneric
01/2020 - 01/2017
2Thymidine Monophosphate (TMP)IBA
01/2020 - 01/2017
2Infliximab (Remicade)FDA Link
09/2016 - 11/2012
2Tumor Necrosis Factor InhibitorsIBA
03/2015 - 12/2014
2Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric
07/2013 - 04/2011
2Methotrexate (Mexate)FDA LinkGeneric
04/2011 - 02/2011
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2011 - 10/2010
1satralizumabIBA
11/2019
1AutoantibodiesIBA
11/2019
1Immunosuppressive Agents (Immunosuppressants)IBA
11/2019
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
06/2018
1golimumabFDA Link
09/2016
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2016
1Tacrolimus (Prograf)FDA LinkGeneric
07/2012
1urinastatin (MR 20)IBA
02/2011
1SteroidsIBA
02/2011

Therapy/Procedure

4Therapeutics
11/2019 - 10/2010
1Activities of Daily Living (ADL)
10/2023
1Renal Dialysis (Hemodialysis)
10/2023
1Surgical Amputation (Amputations)
10/2023
1Chemoprevention
01/2017
1Biological Therapy
11/2012